Hetland TE - Search Results

Year	Number of Results
2008	2
2011	3
2012	6
2013	4
2024	0

1

Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients.

Sioud M, Saebøe-Larssen S, Hetland TE, Kaern J, Mobergslien A, Kvalheim G. Sioud M, et al. Among authors: hetland te. Int J Oncol. 2013 Jul;43(1):280-8. doi: 10.3892/ijo.2013.1922. Epub 2013 Apr 25. Int J Oncol. 2013. PMID: 23620105

2

Seven week culture of functional human mast cells from buffy coat preparations.

Holm M, Andersen HB, Hetland TE, Dahl C, Hoffmann HJ, Junker S, Schiøtz PO. Holm M, et al. Among authors: hetland te. J Immunol Methods. 2008 Jul 31;336(2):213-21. doi: 10.1016/j.jim.2008.04.019. Epub 2008 May 27. J Immunol Methods. 2008. PMID: 18547584

3

Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma.

Vettukattil R, Hetland TE, Flørenes VA, Kærn J, Davidson B, Bathen TF. Vettukattil R, et al. Among authors: hetland te. Hum Pathol. 2013 Sep;44(9):1859-66. doi: 10.1016/j.humpath.2013.02.009. Epub 2013 May 6. Hum Pathol. 2013. PMID: 23656974

4

MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival.

Hetland TE, Nymoen DA, Emilsen E, Kærn J, Tropé CG, Flørenes VA, Davidson B. Hetland TE, et al. Gynecol Oncol. 2012 Sep;126(3):460-5. doi: 10.1016/j.ygyno.2012.05.029. Epub 2012 May 28. Gynecol Oncol. 2012. PMID: 22652154

5

Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival.

Brenne K, Nymoen DA, Hetland TE, Trope' CG, Davidson B. Brenne K, et al. Among authors: hetland te. Hum Pathol. 2012 Apr;43(4):496-505. doi: 10.1016/j.humpath.2011.05.023. Epub 2011 Aug 19. Hum Pathol. 2012. PMID: 21855111

6

Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance.

Hetland TE, Nymoen DA, Holth A, Brusegard K, Flørenes VA, Kærn J, Tropé CG, Davidson B. Hetland TE, et al. Hum Pathol. 2013 May;44(5):777-85. doi: 10.1016/j.humpath.2012.08.002. Epub 2012 Oct 29. Hum Pathol. 2013. PMID: 23114921

7

Gynecologic oncology training systems in Europe: a report from the European network of young gynaecological oncologists.

Gultekin M, Dursun P, Vranes B, Laky R, Bossart M, Grabowski JP, Piek JM, Manchanda R, Grimm C, Dallaku K, Babloyan S, Moisei A, Van Gorp T, Cadron I, Markov P, Micevska A, Halaska M, Steffensen KD, Gristsenko L, Nissi R, Lambaudie E, Tsitsishvili Z, Haidopoulos D, Tsolakidis D, Novak Z, Peiretti M, Dunenova G, Macuks R, Hetland TE, Michelsen TM, Martins FC, Achimas-Cadariu P, Ulrikh EA, Uharcek P, Malic S, Ognjenovic D, Zapardiel I, Johann S, Sukhin VS, Manchanda R. Gultekin M, et al. Among authors: hetland te. Int J Gynecol Cancer. 2011 Nov;21(8):1500-6. doi: 10.1097/IGC.0b013e3182202d17. Int J Gynecol Cancer. 2011. PMID: 21720256

8

Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.

Vaksman O, Hetland TE, Trope' CG, Reich R, Davidson B. Vaksman O, et al. Among authors: hetland te. Hum Pathol. 2012 Nov;43(11):2062-9. doi: 10.1016/j.humpath.2012.02.016. Epub 2012 May 29. Hum Pathol. 2012. PMID: 22647351

9

HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases.

Hetland TE, Holth A, Kærn J, Flørenes VA, Tropé CG, Davidson B. Hetland TE, et al. Virchows Arch. 2012 May;460(5):505-13. doi: 10.1007/s00428-012-1228-9. Epub 2012 Apr 4. Virchows Arch. 2012. PMID: 22476403

10

The need for more workshops in laparoscopic surgery and surgical anatomy for European gynaecological oncology trainees: a survey by the European Network of Young Gynaecological Oncologists.

Manchanda R, Halaska MJ, Piek JM, Grabowski JP, Haidopoulos D, Zapardiel I, Gultekin M, Vranes B, Dallaku K, Bossart M; European Network of Young Gynecological Oncologists (ENYGO). Manchanda R, et al. Int J Gynecol Cancer. 2013 Jul;23(6):1127-32. doi: 10.1097/IGC.0b013e31829703b0. Int J Gynecol Cancer. 2013. PMID: 23792606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year